A new federal framework to improve patient access and health equity

With its landscape focus on reducing the excess burden of disease in vulnerable populations, the Biden administration has clearly renewed its commitment to ending the HIV epidemic by 2030. The path forward must make HIV prevention, care and treatment more accessible and routine. This path includes the importance of drug discovery for new and easier to administer long-acting, antiretroviral treatments (ARVs) to prevent, treat and possibly one day even cure HIV infection.


Read the full piece >